During the third quarter of 2019, we completed the acquisition of BTG plc, integrating its interventional medicine business into our peripheral interventions division, which reflects our strategic initiatives to enhance operational flexibility and adaptability in response to external pressures. Our financial condition and results of operations indicate a positive adjustment under challenging conditions, as evidenced by a net sales increase of 9.3 percent in 2019, driven by operational growth and acquisitions that bolster our competitive advantage. We emphasize the importance of maintaining organizational health through effective resource allocation and risk mitigation strategies, which are critical for sustaining performance under pressure and navigating environmental perturbations. The integration of BTG's technologies into our existing portfolio exemplifies our commitment to service innovation and operational continuity, allowing us to confront unexpected situations and enhance our resilience strategies. Our focus on research and development underscores our belief in the necessity of organizational learning and knowledge management to foster adaptability and transformation in a rapidly evolving market landscape. We have established controls and procedures to manage cybersecurity risks, which are essential for maintaining system integrity and ensuring the reliability of our operations. The implementation of the European Union Medical Device Regulation (EU MDR) is viewed as a significant change that necessitates proactive measures to comply with new standards, thereby reinforcing our organizational resilience. Our liquidity plans are designed to support future growth and operational needs, reflecting our strategic foresight in resource management and deployment. The restructuring initiatives we have undertaken are aimed at optimizing our operational resources and enhancing our organizational effectiveness, which are vital for sustaining performance amidst market volatility. We continue to assess our business environment and adapt our strategies to ensure long-term survival and flourishing, particularly in emerging markets where we have increased our investment in infrastructure. Our commitment to collaboration networks and inter-organizational collaboration further strengthens our capacity to respond to complex situations and maximize opportunities for growth. The ongoing assessment of our legal and product liability matters highlights our awareness of the risks and uncertainties that could impact our operational resilience and financial performance. Overall, our strategic planning and execution reflect a multifaceted approach to organizational resilience, emphasizing the importance of agility, adaptability, and proactive risk management in achieving our major objectives and maintaining a competitive edge in the industry.